Orphan Drugs dominate the shortlist for the 2018 final – while medtech makes its first appearance London, 5thJune, 2018. The pharmaceutical industry’s growing investment in rare diseases has been rewarded with a record number of orphan drugs making the shortlist for one of the most prestigious prizes in pharma R&D – a Prix Galien medal. Seven orphan …
